Education
About Us
Working with TipRanks
Follow Us
Catherine Novack Profile - JonesTrading Analyst
53 Followers
Catherine Novack JonesTrading
Wall Street Analyst
Success Rate
43 out of 114 ratings made a profit
Average Return
+12.90%
Average return per rating
Time Frame
Compare to
Copying Catherine Novack's trades since 2021 and holding each position for 1 Year would result in 37.72% of your transactions generating a profit, with an average return of 12.9% per rating.
Stock Rating Distribution
91.73% Buy
8.27% Hold
0.00% Sell
Distribution of Catherine Novack's ratings
Additional Information
Main Sector:General
Geo Coverage:
US Market
Canadian Market
US MarketCanadian MarketBest Rating
Stock:
Regulus Therapeutics Inc
(RGLS)
(RGLS)
Rating:Buy
Date:Aug 12, 2024 - Apr 30, 2025
Return:+401.80%
The most profitable rating made by Catherine Novack
Catherine Novack's Stock Coverage
Amryt Pharma
Oct 04, 2021
Buy
Initiated
―
1Ratings
-41.00%
Gyre Therapeutics
Nov 15, 2021
Hold
Downgraded
―
4Ratings
-62.85%
Decibel Therapeutics
Aug 09, 2023
Hold
Downgraded
―
4Ratings
+26.20%
Omega Therapeutics
Nov 09, 2023
Buy
Reiterated
$11.00
(25782.35%Upside)
3Ratings
-48.17%
Purple Biotech
Jun 03, 2024
Buy
Reiterated
$60.00
(2097.80%Upside)
4Ratings
+116.60%
Kezar Life Sciences
Sep 30, 2024
Hold
Reiterated
―
5Ratings
-68.65%
Gritstone bio
Oct 01, 2024
Hold
Downgraded
―
5Ratings
-83.88%
Lumos Pharma
Oct 23, 2024
Hold
Downgraded
$4.25
(-2.07%Downside)
4Ratings
+22.25%
Equillium
Oct 31, 2024
Hold
Downgraded
―
4Ratings
+14.53%
Daré Bioscience
Nov 15, 2024
Buy
Reiterated
$13.00
(398.08%Upside)
6Ratings
-43.68%
List of latest recommendations made by Catherine Novack. Click to expand and see Catherine Novack's performance on a particular stock
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed.
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >Catherine Novack activity FAQ
What is the performance of Catherine Novack's recommendations?
The percentage of profitable recommendations made by Catherine Novack is 38%, and the average return per transaction is 12.90%.
What was Catherine Novack's most profitable rating?
Catherine Novack’s most profitable ratings was a buy on RGLS stock on Aug 12, 2024 - Apr 30, 2025. The return on the trade was +401.80%.
Where can I see a list of stock analyst ratings?
You can see a list of daily stock analyst ratings here.
What are the most recommended stocks by analysts?
You can see a list of the most recommended stocks by analysts here